These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3912705)

  • 21. Recent advances in the development of a sporozoite vaccine for malaria.
    Nussenzweig V; Nussenzweig RS
    Asian Pac J Allergy Immunol; 1984 Dec; 2(2):289-92. PubMed ID: 6398085
    [No Abstract]   [Full Text] [Related]  

  • 22. Effects of the antimalarial drugs ferroquine and artesunate on Plasmodium yoelii yoelii gametocytegenesis and vectorial transmission.
    Mustfa K; Landau I; Chabaud AG; Chavatte JM; Chandenier J; Duong TH; Richard-Lenoble D
    Sante; 2011; 21(3):133-42. PubMed ID: 22294247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. L-Arginine supplementation in mice enhances NO production in spleen cells and inhibits Plasmodium yoelii transmission in mosquitoes.
    Zheng L; Pan Y; Feng Y; Cui L; Cao Y
    Parasit Vectors; 2015 Jun; 8():326. PubMed ID: 26070945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide mimics as surrogate immunogens of mosquito midgut carbohydrate malaria transmission blocking targets.
    Dinglasan RR; Porter-Kelley JM; Alam U; Azad AF
    Vaccine; 2005 Apr; 23(21):2717-24. PubMed ID: 15780718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gamete vaccines and transmission-blocking immunity in malaria.
    Gwadz RW; Carter R; Green I
    Bull World Health Organ; 1979; 57 Suppl 1(Suppl):175-80. PubMed ID: 317439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmodium berghei HAP2 induces strong malaria transmission-blocking immunity in vivo and in vitro.
    Blagborough AM; Sinden RE
    Vaccine; 2009 Aug; 27(38):5187-94. PubMed ID: 19596419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced malaria parasite transmission from helminth co-infected mice.
    Noland GS; Graczyk TK; Fried B; Kumar N
    Am J Trop Med Hyg; 2007 Jun; 76(6):1052-6. PubMed ID: 17556610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of Nosema algerae on the development of Plasmodium yoelii nigeriensis in Anopheles stephensi.
    Schenker W; Maier WA; Seitz HM
    Parasitol Res; 1992; 78(1):56-9. PubMed ID: 1584748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Passive immunization against murine malaria with an IgG3 monoclonal antibody.
    Majarian WR; Daly TM; Weidanz WP; Long CA
    J Immunol; 1984 Jun; 132(6):3131-7. PubMed ID: 6725950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Malaria Transmission-Blocking (+)-Usnic Acid Derivative Prevents Plasmodium Zygote-to-Ookinete Maturation in the Mosquito Midgut.
    Pastrana-Mena R; Mathias DK; Delves M; Rajaram K; King JG; Yee R; Trucchi B; Verotta L; Dinglasan RR
    ACS Chem Biol; 2016 Dec; 11(12):3461-3472. PubMed ID: 27978709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmodium sp.: optimal protocols for PCR detection of low parasite numbers from mosquito (Anopheles sp.) samples.
    Arez AP; Lopes D; Pinto J; Franco AS; Snounou G; do Rosário VE
    Exp Parasitol; 2000 Apr; 94(4):269-72. PubMed ID: 10831396
    [No Abstract]   [Full Text] [Related]  

  • 32. Enhanced transmission of malaria parasites to mosquitoes in a murine model of type 2 diabetes.
    Pakpour N; Cheung KW; Luckhart S
    Malar J; 2016 Apr; 15():231. PubMed ID: 27102766
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the modes of action of anti-Pbs21 malaria transmission-blocking immunity: ookinete to oocyst differentiation in vivo.
    Ranawaka GR; Fleck SL; Blanco AR; Sinden RE
    Parasitology; 1994 Nov; 109 ( Pt 4)():403-11. PubMed ID: 7800408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of transgenic Plasmodium berghei expressing the Plasmodium vivax antigen P25 to determine the transmission-blocking activity of sera from malaria vaccine trials.
    Ramjanee S; Robertson JS; Franke-Fayard B; Sinha R; Waters AP; Janse CJ; Wu Y; Blagborough AM; Saul A; Sinden RE
    Vaccine; 2007 Jan; 25(5):886-94. PubMed ID: 17049690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of human malaria transmission by anti-gamete transmission blocking immunity.
    de Zoysa AP; Herath PR; Abhayawardana TA; Padmalal UK; Mendis KN
    Trans R Soc Trop Med Hyg; 1988; 82(4):548-53. PubMed ID: 3076711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trials to infect Anopheles stephensi with Plasmodium yoelii nigeriensis by the membrane feeding technique.
    Chutmongkonkul M; Maier WA; Seitz HM
    Angew Parasitol; 1992 Nov; 33(4):217-25. PubMed ID: 1456466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-gamete antibodies block transmission of human vivax malaria to mosquitoes.
    Munesinghe YD; Mendis KN; Carter R
    Parasite Immunol; 1986 May; 8(3):231-8. PubMed ID: 3523397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Innate immune defense in anopheline mosquitoes against plasmodium infection].
    Qiu ZW; Zhang XL
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Oct; 24(5):370-4. PubMed ID: 17361820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization with the malaria heat shock like protein hsp70-1 enhances transmission to the mosquito.
    Motard A; Marussig M; Rénia L; Baccam D; Landau I; Mattei D; Targett G; Mazier D
    Int Immunol; 1995 Jan; 7(1):147-50. PubMed ID: 7718511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transmission blockade of Plasmodium falciparum: its variability with gametocyte numbers and concentration of antibody.
    Ponnudurai T; van Gemert GJ; Bensink T; Lensen AH; Meuwissen JH
    Trans R Soc Trop Med Hyg; 1987; 81(3):491-3. PubMed ID: 3318022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.